Home » Topics » BioWorld Science

BioWorld Science
RSS

Invio cuts select early R&D programs to focus on HPV-related diseases

July 17, 2019

FDA approves Recarbrio for complicated urinary tract and intra-abdominal infections

July 17, 2019

Cyclica and University of Toronto enter EGFR inhibitor collaboration

July 17, 2019

FDA clears investigator-initiated phase II trial of GKT-831 for IPF

July 17, 2019

Researchers in search of small-molecule NAMPT activators for Alzheimer's disease

July 17, 2019

Mallinckrodt discontinues phase IIb study of Acthar gel in ALS

July 17, 2019

MDA funding supports development of small-molecule drugs to increase sarcospan expression for DMD

July 17, 2019

Affibody completes 12-week interim analysis of phase II psoriasis study of ABY-035

July 17, 2019

Skyhawk and Genentech to discover and develop small-molecule RNA splicing modifiers

July 17, 2019

Bristol-Myers Squibb presents Toll-like receptor antagonists

July 17, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...